{"transactions":[{"id":1045754,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant to Purchase Common Shares","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-29","kind":"purchase","planned":false,"acquired":true,"shares":3139533,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On July 29, 2025, the JS Trust acquired a warrant to purchase 3,139,533 Common Shares at an exercise price of $1.25 per share. The purchase price for the warrant was $0.1875 per Common Share underlying the warrant. The warrant is currently exercisable and expires five years after the date of issuance."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":3139533,"derivative":{"underlying":"Common Shares","underlying_shares":3139533},"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1045753,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Tranche C Common Share Purchase Warrants","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-25","kind":"other","planned":false,"acquired":false,"shares":697674,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":697674},"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1045752,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Tranche B Common Share Purchase Warrants","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-25","kind":"other","planned":false,"acquired":false,"shares":697674,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":697674},"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1045751,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Tranche A Common Share Purchase Warrants","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-25","kind":"other","planned":false,"acquired":false,"shares":697674,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the \"JS Trust\") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the \"JS Trust\") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the \"JS Trust\") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":697674},"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1045750,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, no par value","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-25","kind":"other","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"By JS Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.50 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":3710459,"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1045749,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, no par value","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-25","kind":"other","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"By JS Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On July 25, 2025, the JS Trust exercised 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":3012785,"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1045748,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, no par value","published_at":"2025-09-08T20:10:26.000Z","date":"2025-07-25","kind":"other","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"By: Jeremy M. Sclar 2012 Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the \"JS Trust\") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 25, 2025, the Jeremy M. Sclar 2012 Irrevocable Family Trust (the \"JS Trust\") exercised 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share. These warrants were exercisable at an exercise price of $2.02 per warrant share; however, following an offer by the JS Trust and an acceptance by the Issuer, were exercised in full at an exercise price of $0.83518 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the JS Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts. Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":2315111,"source":{"system":"sec-edgar","filing":"0001104659-25-088246","document":"tm2522972-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465925088246/tm2522972-1_4seq1.xml","form_type":"4"}},{"id":1442754,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 2 Preferred Shares, no par value","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held through Crocker Mountain LLC, a Maine Limited liability company (\"Crocker Mountain\"). Mr Sclar is the sole manager of Crocker Mountain."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442753,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 2 Preferred Shares, no par value","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":0,"derivative":{"underlying":"Common Shares","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442752,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Tranche C Common Share Purchase Warrants","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"Consists of 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.50 per warrant share. These warrants are currently exercisable and expire on July 31, 2029."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Consists of 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.50 per warrant share. These warrants are currently exercisable and expire on July 31, 2029."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Consists of 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.50 per warrant share. These warrants are currently exercisable and expire on July 31, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Consists of 697,674 Tranche C purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.50 per warrant share. These warrants are currently exercisable and expire on July 31, 2029."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":697674,"derivative":{"underlying":"Common Shares","underlying_shares":697674},"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442751,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Tranche B Common Share Purchase Warrants","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Consists of 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche B purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 30 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 12-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Consists of 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche B purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 30 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 12-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Consists of 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche B purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 30 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 12-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Consists of 697,674 Tranche B purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that such approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche B purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 30 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 12-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":697674,"derivative":{"underlying":"Common Shares","underlying_shares":697674},"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442750,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Tranche A Common Share Purchase Warrants","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Consists of 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche A purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 18 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 6-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Consists of 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche A purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 18 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 6-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Consists of 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche A purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 18 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 6-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Consists of 697,674 Tranche A purchase warrants, each exercisable to purchase one Common Share at an exercise price of $2.02 per warrant share. These warrants are immediately exercisable beginning on the date that approval as may be required by the applicable rules and regulations of the Nasdaq Stock Market LLC (or any successor entity) from the shareholders of the Issuer with respect to the issuance of the Tranche A purchase warrants and the Common Shares upon the exercise thereof is received and deemed effective under Ontario law. These warrants expire on the earlier of (i) 18 months and (ii) within 60 days of the public announcement via press release or the filing of a Current Report on Form 8-K of 6-month data from the cohorts treated with single ascending doses of PMN310."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":697674,"derivative":{"underlying":"Common Shares","underlying_shares":697674},"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442749,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, no par value","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":false,"nature":"By Crocker Mountain LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held through Crocker Mountain LLC, a Maine Limited liability company (\"Crocker Mountain\"). Mr Sclar is the sole manager of Crocker Mountain."}],"balance_after":1155726,"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442748,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, no par value","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"exercise","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":false,"nature":"By JS Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The Series 2 Preferred Shares involuntarily converted into Common Shares at a 1:1 ratio upon the closing of the Offering, which was a cumulative qualified equity financing in excess of $14 million."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":1617437,"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1442747,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Shares, no par value","published_at":"2024-08-02T20:15:11.000Z","date":"2024-07-31","kind":"purchase","planned":false,"acquired":true,"shares":697674,"ownership":{"direct":false,"nature":"By: Jeremy M. Sclar 2012 Irrevocable Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 31, 2024, the Jeremy M. Sclar 2012 Irrevocable Family Trust acquired 697,674 units, each consisting of (a) one Common Share, (b) one Tranche A Common Share purchase warrant, (c) one Tranche B Common Share purchase warrant and (iv) one Tranche C Common Share purchase warrant, in a private placement (the \"Offering\") conducted by the Issuer. The purchase price for each Unit was $2.15 per Unit."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":1467437,"source":{"system":"sec-edgar","filing":"0001104659-24-085369","document":"tm2420441-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924085369/tm2420441-3_4seq1.xml","form_type":"4"}},{"id":1696360,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants to Purchase Common Shares, no par value","published_at":"2024-01-02T19:45:56.000Z","date":"2022-10-11","kind":"purchase","planned":false,"acquired":true,"shares":26217,"ownership":{"direct":false,"nature":"By: JS Trust"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F8","text":"Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Consists of 26,217 warrants to purchase Common Shares, each exercisable to purchase one Common Share at an exercise price of $7.50 per whole warrant. These warrants are part of Units, each consisting of one Common Share and one-quarter of one warrant to purchase one Common Share. The purchase price for each Unit was $5.40. These warrants are currently exercisable and expire on April 11, 2028, the fifth anniversary of the date the warrants first become exercisable. These warrants were inadvertently omitted from Mr. Sclar's Form 3 filed on September 5, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":26217,"derivative":{"underlying":"Common Stock","underlying_shares":26217},"source":{"system":"sec-edgar","filing":"0001104659-24-000270","document":"tm2333203-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924000270/tm2333203-2_4seq1.xml","form_type":"4"}},{"id":1696359,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 2 Preferred Shares, no par value","published_at":"2024-01-02T19:45:56.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":false,"nature":"By: JS Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The Series 2 Preferred Shares are nonvoting and noninterest bearing and are currently convertible at a 1:1 ratio into Common Shares at the option of the holder. The Series 2 Preferred Shares will involuntarily convert into Common Shares upon cumulative qualified equity financing in excess of $14 million."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"150,000 Common Shares underlying 150,000 Series 2 Preferred Shares, each convertible into 1 Common Share in accordance with the terms of the Series 2 Preferred Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 4, 2023, the issuer entered into a Share Exchange Agreement with the holders of the issuer's Series 1 Preferred Shares, pursuant to which the Series 1 Preferred Shares were exchanged for a new class of Series 2 convertible preferred shares (the \"Series 2 Preferred Shares\"), effected on a 60:1 basis to reflect the Stock Split, such that the 9,000,000 Series 1 Preferred Shares held were exchanged for 150,000 Series 2 Preferred Shares, convertible, at the option of the holder, at any time and from time to time, into an aggregate of 150,000 Common Shares in accordance with the terms of the Series 2 Preferred Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"150,000 Common Shares underlying 150,000 Series 2 Preferred Shares, each convertible into 1 Common Share in accordance with the terms of the Series 2 Preferred Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"150,000 Common Shares underlying 150,000 Series 2 Preferred Shares, each convertible into 1 Common Share in accordance with the terms of the Series 2 Preferred Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-24-000270","document":"tm2333203-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924000270/tm2333203-2_4seq1.xml","form_type":"4"}},{"id":1696358,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1 Preferred Shares, no par value","published_at":"2024-01-02T19:45:56.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":false,"nature":"By: Jeremy M. Sclar 2012 Irrevocable Family Trust"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Series 1 Preferred Shares were nonvoting and noninterest bearing and were convertible at a 60:1 ratio into Common Shares at the option of the holder. The Series 1 Preferred Shares would involuntarily convert into Common Shares upon cumulative qualified equity financing in excess of $30 million."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"150,000 Common Shares underlying 9,000,000 Series 1 Preferred Shares, each initially convertible into 1 Common Share in accordance with the terms of the Series 1 Preferred Shares, and, as a result of a 60:1 stock split (the \"Stock Split\") of the issuer that occurred in June 2022, became convertible into an aggregate of 150,000 Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 4, 2023, the issuer entered into a Share Exchange Agreement with the holders of the issuer's Series 1 Preferred Shares, pursuant to which the Series 1 Preferred Shares were exchanged for a new class of Series 2 convertible preferred shares (the \"Series 2 Preferred Shares\"), effected on a 60:1 basis to reflect the Stock Split, such that the 9,000,000 Series 1 Preferred Shares held were exchanged for 150,000 Series 2 Preferred Shares, convertible, at the option of the holder, at any time and from time to time, into an aggregate of 150,000 Common Shares in accordance with the terms of the Series 2 Preferred Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"150,000 Common Shares underlying 9,000,000 Series 1 Preferred Shares, each initially convertible into 1 Common Share in accordance with the terms of the Series 1 Preferred Shares, and, as a result of a 60:1 stock split (the \"Stock Split\") of the issuer that occurred in June 2022, became convertible into an aggregate of 150,000 Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"150,000 Common Shares underlying 9,000,000 Series 1 Preferred Shares, each initially convertible into 1 Common Share in accordance with the terms of the Series 1 Preferred Shares, and, as a result of a 60:1 stock split (the \"Stock Split\") of the issuer that occurred in June 2022, became convertible into an aggregate of 150,000 Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F7","text":"Held through the Jeremy M. Sclar 2012 Irrevocable Family Trust, a trust formed under a trust instrument governed by the laws of the Commonwealth of Massachusetts (\"JS Trust\"). Mr Sclar's spouse is one of the trustees of the JS Trust."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-24-000270","document":"tm2333203-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924000270/tm2333203-2_4seq1.xml","form_type":"4"}},{"id":1696357,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 2 Preferred Shares, no par value","published_at":"2024-01-02T19:45:56.000Z","date":"2023-12-04","kind":"purchase","planned":false,"acquired":true,"shares":150000,"ownership":{"direct":false,"nature":"By: Crocker Mountain"},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"The Series 2 Preferred Shares are nonvoting and noninterest bearing and are currently convertible at a 1:1 ratio into Common Shares at the option of the holder. The Series 2 Preferred Shares will involuntarily convert into Common Shares upon cumulative qualified equity financing in excess of $14 million."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"150,000 Common Shares underlying 150,000 Series 2 Preferred Shares, each convertible into 1 Common Share in accordance with the terms of the Series 2 Preferred Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 4, 2023, the issuer entered into a Share Exchange Agreement with the holders of the issuer's Series 1 Preferred Shares, pursuant to which the Series 1 Preferred Shares were exchanged for a new class of Series 2 convertible preferred shares (the \"Series 2 Preferred Shares\"), effected on a 60:1 basis to reflect the Stock Split, such that the 9,000,000 Series 1 Preferred Shares held were exchanged for 150,000 Series 2 Preferred Shares, convertible, at the option of the holder, at any time and from time to time, into an aggregate of 150,000 Common Shares in accordance with the terms of the Series 2 Preferred Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"150,000 Common Shares underlying 150,000 Series 2 Preferred Shares, each convertible into 1 Common Share in accordance with the terms of the Series 2 Preferred Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"150,000 Common Shares underlying 150,000 Series 2 Preferred Shares, each convertible into 1 Common Share in accordance with the terms of the Series 2 Preferred Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held through Crocker Mountain LLC, a Maine Limited liability company (\"Crocker Mountain\"). Mr Sclar is the sole manager of Crocker Mountain."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-24-000270","document":"tm2333203-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924000270/tm2333203-2_4seq1.xml","form_type":"4"}},{"id":1696356,"issuer":{"id":6643,"kind":"organization","name":"ProMIS Neurosciences Inc.","symbol":"PMN"},"owners":[{"id":75665,"kind":"person","name":"Sclar Jeremy M.","position":1,"cik":"0001955608","reported_name":"Sclar Jeremy M.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series 1 Preferred Shares, no par value","published_at":"2024-01-02T19:45:56.000Z","date":"2023-12-04","kind":"sale","planned":false,"acquired":false,"shares":150000,"ownership":{"direct":false,"nature":"By: Crocker Mountain LLC"},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Series 1 Preferred Shares were nonvoting and noninterest bearing and were convertible at a 60:1 ratio into Common Shares at the option of the holder. The Series 1 Preferred Shares would involuntarily convert into Common Shares upon cumulative qualified equity financing in excess of $30 million."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"150,000 Common Shares underlying 9,000,000 Series 1 Preferred Shares, each initially convertible into 1 Common Share in accordance with the terms of the Series 1 Preferred Shares, and, as a result of a 60:1 stock split (the \"Stock Split\") of the issuer that occurred in June 2022, became convertible into an aggregate of 150,000 Common Shares."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"On December 4, 2023, the issuer entered into a Share Exchange Agreement with the holders of the issuer's Series 1 Preferred Shares, pursuant to which the Series 1 Preferred Shares were exchanged for a new class of Series 2 convertible preferred shares (the \"Series 2 Preferred Shares\"), effected on a 60:1 basis to reflect the Stock Split, such that the 9,000,000 Series 1 Preferred Shares held were exchanged for 150,000 Series 2 Preferred Shares, convertible, at the option of the holder, at any time and from time to time, into an aggregate of 150,000 Common Shares in accordance with the terms of the Series 2 Preferred Shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"150,000 Common Shares underlying 9,000,000 Series 1 Preferred Shares, each initially convertible into 1 Common Share in accordance with the terms of the Series 1 Preferred Shares, and, as a result of a 60:1 stock split (the \"Stock Split\") of the issuer that occurred in June 2022, became convertible into an aggregate of 150,000 Common Shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"150,000 Common Shares underlying 9,000,000 Series 1 Preferred Shares, each initially convertible into 1 Common Share in accordance with the terms of the Series 1 Preferred Shares, and, as a result of a 60:1 stock split (the \"Stock Split\") of the issuer that occurred in June 2022, became convertible into an aggregate of 150,000 Common Shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Held through Crocker Mountain LLC, a Maine Limited liability company (\"Crocker Mountain\"). Mr Sclar is the sole manager of Crocker Mountain."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001104659-24-000270","document":"tm2333203-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374339/000110465924000270/tm2333203-2_4seq1.xml","form_type":"4"}}]}